Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Strontium-89

Known as: Strontium Sr-89, strontium (89Sr) chloride, strontium 89 
A radioisotope of strontium, a heavy metal found naturally as a non-radioactive element. With a half-life of 50 days, strontium-89 is a beta emitter… Expand
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (3)

MetastronStrontium-89 chloridestrontium chloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration…
BACKGROUND Bony metastatic castration-refractory prostate cancer is associated with a poor prognosis and high morbidity. TRAPEZE… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial
BACKGROUND Prostate carcinoma is linked to osteoblastic metastasis. We therefore investigated the value of bone-targeted… Expand
Is this relevant?
2001
2001
Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer
93 patients with hormone refractory metastatic prostate cancer were entered on a prospective study to measure reduction in pain… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
Review
1995
Review
1995
Strontium 89 therapy for the palliation of pain due to osseous metastases.
OBJECTIVE To present the current state of systemic radiopharmaceutical therapy for the palliation of pain in individuals with… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.
From 1988 to 1991, 284 patients with prostatic cancer and painful bone metastases were treated with either radiotherapy or… Expand
  • table I
  • figure 1
  • table 2
  • figure I
  • figure 2
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
PURPOSE A large proportion of the practice of radiotherapy in the management of metastatic adenocarcinoma of the prostate is… Expand
Is this relevant?
1987
1987
Treatment of metastatic bone pain with strontium-89.
We have utilized 89Sr as palliative treatment for bone pain secondary to metastatic cancer in the skeleton of over 200 patients… Expand
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Strontium-89 therapy for the pain of osseous metastases.
A Phase I and II study has been conducted of the safety and efficacy of 89Sr (injected i.v. as the chloride) to alleviate bone… Expand
Is this relevant?
Highly Cited
1982
Highly Cited
1982
Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89.
The capacity of resident peritoneal macrophages and alveolar macrophages for self-renewal was studied in CD-1 mice depleted of… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE